AR063988A1 - HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
AR063988A1
AR063988A1 ARP070105256A ARP070105256A AR063988A1 AR 063988 A1 AR063988 A1 AR 063988A1 AR P070105256 A ARP070105256 A AR P070105256A AR P070105256 A ARP070105256 A AR P070105256A AR 063988 A1 AR063988 A1 AR 063988A1
Authority
AR
Argentina
Prior art keywords
branched
linear
alkyl
substituted
pharmaceutical compositions
Prior art date
Application number
ARP070105256A
Other languages
Spanish (es)
Inventor
Alain Ktorza
Daniel-Henri Caignard
Rene Gree
Julien Brioche
Thomas Jennequin
Frederic Caijo
Catherine Dacquet
Melanie Liutkus
Original Assignee
Servier Lab
Le Ct Nat De La Rech Scient Cn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Le Ct Nat De La Rech Scient Cn filed Critical Servier Lab
Publication of AR063988A1 publication Critical patent/AR063988A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)

Abstract

Reivindicacion 1: Compuestos de formula (1) en la que R1 representa alquilo C1-6 lineal o ramificado sustituido con uno o varios grupos COOR3 o NR4R5, en los que R3 representa un átomo de H o alquilo C1-6 lineal o ramificado; R4 representa un grupo COOR'3 o alquilo C1-6 lineal o ramificado sustituido con un grupo COOR'3 en el que R'3 representa un átomo de H o alquilo C1-6 lineal o ramificado; R5 representa alquilo C1-6 lineal o ramificado sustituido con un grupo fenilo no sustituido o sustituido con 1 a 3 grupos alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, polihaloalquilo C1-6 lineal o ramificado o átomos de halogeno; R2 representa un grupo fenilo no sustituido o sustituido con uno o varios grupos alquilo C1- 6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, polihaloalquilo C1-6 lineal o ramificado o átomos de halogeno, n vale 0, 1, 2, 3, 4, 5, 6, 7 u 8, sus enantiomeros y diastereoisomeros así como sus sales de adicion a un ácido o a una base aceptables farmacéuticamente.Claim 1: Compounds of formula (1) wherein R1 represents linear or branched C1-6 alkyl substituted with one or more COOR3 or NR4R5 groups, wherein R3 represents a linear or branched C1-6 alkyl or H atom; R4 represents a linear or branched COOR'3 or C1-6 alkyl group substituted with a COOR'3 group in which R'3 represents a linear or branched C1-6 alkyl or H atom; R5 represents linear or branched C1-6 alkyl substituted with a phenyl group unsubstituted or substituted with 1 to 3 linear or branched C1-6 alkyl groups, linear or branched C1-6 alkoxy, linear or branched C1-6 polyhaloalkyl or halogen atoms ; R2 represents a phenyl group unsubstituted or substituted with one or more linear or branched C1-6 alkyl, linear or branched C1-6 alkoxy, linear or branched C1-6 polyhaloalkyl or halogen atoms groups, worth 0, 1, 2, 3, 4, 5, 6, 7 or 8, their enantiomers and diastereoisomers as well as their addition salts to a pharmaceutically acceptable acid or base.

ARP070105256A 2006-11-30 2007-11-28 HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AR063988A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610458A FR2909379B1 (en) 2006-11-30 2006-11-30 NOVEL HETEROCYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Publications (1)

Publication Number Publication Date
AR063988A1 true AR063988A1 (en) 2009-03-04

Family

ID=38283326

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105256A AR063988A1 (en) 2006-11-30 2007-11-28 HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (3)

Country Link
AR (1) AR063988A1 (en)
FR (1) FR2909379B1 (en)
WO (1) WO2008081096A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522750A (en) 2009-04-01 2012-09-27 ビーエーエスエフ ソシエタス・ヨーロピア Isoxazoline compounds for combating invertebrate pests
HUE035069T2 (en) 2011-12-28 2018-05-02 Global Blood Therapeutics Inc Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
CN105073728A (en) 2013-03-15 2015-11-18 全球血液疗法股份有限公司 Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (en) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc COMPOUNDS AND THEIR USES TO MODULATE HEMOGLOBIN
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CA2903022C (en) 2013-03-15 2021-11-09 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (en) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION
AP2016009261A0 (en) 2014-02-07 2016-06-30 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (en) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc ALDEHYDE COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, HYPOXIA, AND AUTOIMMUNE AND CONNECTIVE TISSUE DISEASES
MX2018006832A (en) 2015-12-04 2018-11-09 Global Blood Therapeutics Inc Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl) pyridin-3-yl)methoxy)benzaldehyde.
TWI752307B (en) 2016-05-12 2022-01-11 美商全球血液治療公司 Novel compound and method of preparing compound
TW202332423A (en) 2016-10-12 2023-08-16 美商全球血液治療公司 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
WO2020072377A1 (en) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345083A (en) * 1978-09-18 1982-08-17 Mcneilab, Inc. (1-Methyl-2-quinolinylidene) derivatives of guanidine
FR2869611B1 (en) * 2004-05-03 2006-07-28 Merck Sante Soc Par Actions Si HEXENOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC APPLICATIONS
FR2869615B1 (en) * 2004-05-03 2007-11-16 Merck Sante Soc Par Actions Si BUTANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC APPLICATIONS THEREOF
FR2881137B1 (en) * 2005-01-27 2007-03-02 Servier Lab NOVEL HETEROCYCLIC OXIMIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Also Published As

Publication number Publication date
WO2008081096A2 (en) 2008-07-10
WO2008081096A3 (en) 2008-08-21
FR2909379A1 (en) 2008-06-06
FR2909379B1 (en) 2009-01-16

Similar Documents

Publication Publication Date Title
AR063988A1 (en) HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR052568A1 (en) DERIVATIVES OF PIRAZOLO-PYRIMIDINE AS ANGLOSTS OF MGLUR2
CR10643A (en) DERIVATIVES OF 2-ARIL-6-FENIL-IMIDAZOL [1,2-a] PIRIDINAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR062677A1 (en) DERIVATIVES OF BIARIL-SULFONAMIDE, PRODUCTION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
AR060489A1 (en) BENZOAZEPIN ACID DERIVATIVES - OXI- ACETIC AS A PPAR - DELTA AGONIST USED TO INCREASE HDL-C, REDUCE LDL-C AND REDUCE CHOLESTEROL
NI201000022A (en) NEW 6-TRIAZOLOPYRIDACINE-SULFANIL BENZOTHIAZOLE AND BENZHIMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE MAINLY AS MET INHIBITORS.
ECSP088731A (en) DERIVATIVES OF 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RS52978B (en) Fused amino pyridine as hsp90 inhibitors
AR061835A1 (en) TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR086538A1 (en) COMPOUNDS TO REDUCE THE PRODUCTION OF B-AMYLOID
AR073136A1 (en) PIRROL COMPOUNDS
AR053554A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
AR053453A1 (en) SUBSTITUTED AMINOALQUIL- AND AMIDOALQUIL-BENZOPIRANO DERIVATIVES
AR075892A1 (en) DERIVATIVES OF BENZOTIADIAZEPINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR074053A1 (en) ANILINA-PYRIMIDINE DERIVATIVES REPLACED WITH SULFOXIMINE AS INHIBITORS OF CYCLINE-DEPENDENT KINASE (CDK), AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR073043A1 (en) COMPOUNDS OF POLYSUSTITUTED AZETIDINS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHOD OF PREPARATION AND USE OF THE SAME IN THE TREATMENT OF RESPIRATORY, METABOLIC DISEASES AND OF THE CENTRAL NERVOUS SYSTEM, AMONG OTHERS.
RS53389B (en) Pharmaceutical compounds
ECSP10010380A (en) NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR064424A1 (en) SUBSTITUTED DERIVATIVES OF 1-OXO-FTALAZINAS and 1-OXO-PIRIDO-PIRIDAZINAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USES TO PREVENT AND / OR TREAT INFLAMMATORY AND ALLERGIC DISEASES OF RESPIRATORY TRACT.
AR069643A1 (en) DIAZENIDIOLATE DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR063328A1 (en) INDOLIC DERIVATIVES ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR072103A1 (en) DERIVATIVES OF (PIPERAZINILO WITH BRIDGE LINKS) -1- ALCANONA, ITS USE AS P75 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR054584A1 (en) ISOTOPICALLY REPLACED PROTON PUMP INHIBITORS
AR043186A1 (en) INDOZOLAMIDS PROVIDED WITH ANALGESIC ACTIVITY, METHOD OF PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOUND THAT INCLUDES THEM
AR072486A1 (en) CYCLE-RENTED BENZOTIADIAZINE DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FB Suspension of granting procedure